Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 23 Apr 2023
The treatment of chronic thromboembolic pulmonary hypertension with balloon pulmonary angioplasty has an evolving safety profile over the years, from 2013 to 2022, as revealed by an analysis of more than two dozen studies.
Read Full NewsA nurse practitioner-led outreach program improves the rates of breast and cervical cancer screening among women veterans in rural areas, a retrospective study shows.
Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.
1.
Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?
2.
A single bout of exercise gives results that could help cancer patients
3.
Detecting invasive nodules could be key to preventing unnecessary pancreatic cancer surgery
4.
Is a $2,000 Whole-Body MRI Worth It?
5.
Unraveling the role of exercise in cancer suppression
1.
Liquid Biopsy: Revolutionizing Precision Oncology in Hematological Malignancies
2.
Frontiers in Cancer Therapeutics: U.S. Oncology Trials and Drug Discovery Trends
3.
Omitting Axillary Dissection in Node-Positive Breast Cancer: Insights from the SENOMAC Trial
4.
Leukemia: Understanding the Disease and Its Impact on Patients
5.
Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Navigating the Complexities of Ph Negative ALL - Part I
4.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge